• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Phlebitis (2004); Thrombus (2101)
Event Date 07/12/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the physician used the venaseal to successfully treat the right great saphenous vein(gsv), as per ifu.It was reported the patient attended a scan 6 days post procedure.The patient presented with severe pain in the treated limb and was diagnosed with phlebitis.The ultrasound showed an ehit (endovenous heat induced thrombus) class 2.The patient was prescribed ibuprofen 600mg x3, daily and tramadol-50mg 1-2 tabs every 6 hours or when necessary.
 
Manufacturer Narrative
Additional information: approx 1.5cc of cyanoacrylate was used to treat a 31 cm length.The patient continues to do well.The physician added that the patients coat profile was positive for elevated factor viii levels and heterozygous mthfr genetics- both putting her at increased risk of dvt the device was not received for evaluation.Six sonographic images were received for evaluation of the saphenofemoral junction (sfj) and great saphenous vein (gsv).Images 1 and 2 (time stamp az 07/12/2018 09:45:31am) are cross sectional views showing a thrombosis formation extending from the gsv into the sfj.Image 2 is of the vessel anatomy under compression.Images 3 and 4 (time stamp az 07/12/2018 09:43:46am) are cross sectional views showing a thrombosis formation in the sfj.Image 4 is of the vessel anatomy under compression.Image 5 (time stamp az 07/12/2018 09:49:03am) is a longitudinal view showing a thrombosis formation extending from the gsv into the sfj.Image 6 (time stamp az 07/12/2018 09:53:14am) is a longitudinal view showing a thrombosis formation extending from the gsv into the sfj.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7717455
MDR Text Key114933669
Report Number9612164-2018-01849
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/25/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2020
Device Catalogue NumberVS-402
Device Lot Number50655
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/08/2018
Date Device Manufactured03/05/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
Patient Weight65
-
-